Viewing Study NCT02019069


Ignite Creation Date: 2025-12-24 @ 11:13 PM
Ignite Modification Date: 2026-02-22 @ 12:42 AM
Study NCT ID: NCT02019069
Status: COMPLETED
Last Update Posted: 2019-01-22
First Post: 2013-11-25
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: CPX-351 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
Sponsor: Rondeep Brar
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adult Acute Erythroid Leukemia (M6) View
None Adult Acute Megakaryoblastic Leukemia (M7) View
None Adult Acute Minimally Differentiated Myeloid Leukemia (M0) View
None Adult Acute Monoblastic Leukemia and Acute Monocytic Leukemia (M5) View
None Adult Acute Myeloblastic Leukemia With Maturation (M2) View
None Adult Acute Myeloblastic Leukemia Without Maturation (M1) View
None Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities View
None Adult Acute Myeloid Leukemia With Del(5q) View
None Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) View
None Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) View
None Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) View
None Adult Acute Myelomonocytic Leukemia (M4) View
None de Novo Myelodysplastic Syndromes View
None Previously Treated Myelodysplastic Syndromes View
None Recurrent Adult Acute Myeloid Leukemia View
None Secondary Myelodysplastic Syndromes View
Keywords: